Praesidian Capital Acquires Genetics Business
NEW YORK – September 18, 2019 -Praesidian Capital, a leading private investment firm, announced today that it acquired an integrated clinical and laboratory services company in the high-growth field of genetic medicine. The company is a leader in the prenatal and preconception field, and it also provides hereditary cancer risk assessments. This is Praesidian’s first…